Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.
"Day-7" myeloid DCs are commonly used in the clinic. However, there is a strong need to develop DCs faster that have the same potent immunostimulatory capacity as "Day-7" myeloid DCs and at the same time minimizing time, labor and cost of DC preparations. Although "2 days&qu...
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Public Library of Science (PLoS)
2011-01-01
|
| سلاسل: | PLoS ONE |
| الوصول للمادة أونلاين: | http://europepmc.org/articles/PMC3237492?pdf=render |
| _version_ | 1828189449928835072 |
|---|---|
| author | Cheryl Lai-Lai Chiang Andrea R Hagemann Rachel Leskowitz Rosemarie Mick Thomas Garrabrant Brian J Czerniecki Lana E Kandalaft Daniel J Powell George Coukos |
| author_facet | Cheryl Lai-Lai Chiang Andrea R Hagemann Rachel Leskowitz Rosemarie Mick Thomas Garrabrant Brian J Czerniecki Lana E Kandalaft Daniel J Powell George Coukos |
| author_sort | Cheryl Lai-Lai Chiang |
| collection | DOAJ |
| description | "Day-7" myeloid DCs are commonly used in the clinic. However, there is a strong need to develop DCs faster that have the same potent immunostimulatory capacity as "Day-7" myeloid DCs and at the same time minimizing time, labor and cost of DC preparations. Although "2 days" DCs can elicit peptide-specific responses, they have not been demonstrated to engulf, process and present complex whole tumor lysates, which could be more convenient and personalized source of tumor antigens than defined peptides. In this preclinical study, we evaluated the T-cell stimulatory capacity of Day-2, Day-4, and Day-7 cultured monocyte-derived DCs loaded with SKOV3 cell whole lysate prepared by freeze-thaw or by UVB-irradiation followed by freeze-thaw, and matured with lipopolysaccharide (LPS) and interferon (IFN)-gamma. DCs were evaluated for antigen uptake, and following maturation with LPS and IFN-gamma, DCs were assessed for expression of CD80, CD40, CD86, ICAM-1 and CCR7, production of IL-12p70 and IP-10, and induction of tumor-specific T-cell responses. Day-4 and Day-7 DCs exhibited similar phagocytic abilities, which were superior to Day-2 DCs. Mature Day-7 DCs expressed the highest CD40 and ICAM-1, but mature Day-4 DCs produced the most IL-12p70 and IP-10. Importantly, Day-4 and Day-7 DCs derived from ovarian cancer patients stimulated equally strongly tumor-specific T-cell responses. This is the first study demonstrating the highly immunogenic and strong T-cell stimulatory properties of Day-4 myeloid DCs, and provided important preclinical data for rapid development of potent whole tumor lysate-loaded DC vaccines that are applicable to many tumor types. |
| first_indexed | 2024-04-12T08:05:56Z |
| format | Article |
| id | doaj.art-a9c0fda4b0b64a82856d709826918e1a |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T08:05:56Z |
| publishDate | 2011-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-a9c0fda4b0b64a82856d709826918e1a2022-12-22T03:41:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01612e2873210.1371/journal.pone.0028732Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.Cheryl Lai-Lai ChiangAndrea R HagemannRachel LeskowitzRosemarie MickThomas GarrabrantBrian J CzernieckiLana E KandalaftDaniel J PowellGeorge Coukos"Day-7" myeloid DCs are commonly used in the clinic. However, there is a strong need to develop DCs faster that have the same potent immunostimulatory capacity as "Day-7" myeloid DCs and at the same time minimizing time, labor and cost of DC preparations. Although "2 days" DCs can elicit peptide-specific responses, they have not been demonstrated to engulf, process and present complex whole tumor lysates, which could be more convenient and personalized source of tumor antigens than defined peptides. In this preclinical study, we evaluated the T-cell stimulatory capacity of Day-2, Day-4, and Day-7 cultured monocyte-derived DCs loaded with SKOV3 cell whole lysate prepared by freeze-thaw or by UVB-irradiation followed by freeze-thaw, and matured with lipopolysaccharide (LPS) and interferon (IFN)-gamma. DCs were evaluated for antigen uptake, and following maturation with LPS and IFN-gamma, DCs were assessed for expression of CD80, CD40, CD86, ICAM-1 and CCR7, production of IL-12p70 and IP-10, and induction of tumor-specific T-cell responses. Day-4 and Day-7 DCs exhibited similar phagocytic abilities, which were superior to Day-2 DCs. Mature Day-7 DCs expressed the highest CD40 and ICAM-1, but mature Day-4 DCs produced the most IL-12p70 and IP-10. Importantly, Day-4 and Day-7 DCs derived from ovarian cancer patients stimulated equally strongly tumor-specific T-cell responses. This is the first study demonstrating the highly immunogenic and strong T-cell stimulatory properties of Day-4 myeloid DCs, and provided important preclinical data for rapid development of potent whole tumor lysate-loaded DC vaccines that are applicable to many tumor types.http://europepmc.org/articles/PMC3237492?pdf=render |
| spellingShingle | Cheryl Lai-Lai Chiang Andrea R Hagemann Rachel Leskowitz Rosemarie Mick Thomas Garrabrant Brian J Czerniecki Lana E Kandalaft Daniel J Powell George Coukos Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. PLoS ONE |
| title | Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. |
| title_full | Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. |
| title_fullStr | Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. |
| title_full_unstemmed | Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. |
| title_short | Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. |
| title_sort | day 4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti tumor responses |
| url | http://europepmc.org/articles/PMC3237492?pdf=render |
| work_keys_str_mv | AT cheryllailaichiang day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT andrearhagemann day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT rachelleskowitz day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT rosemariemick day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT thomasgarrabrant day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT brianjczerniecki day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT lanaekandalaft day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT danieljpowell day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses AT georgecoukos day4myeloiddendriticcellspulsedwithwholetumorlysatearehighlyimmunogenicandelicitpotentantitumorresponses |